IgE immunotoxins. Effect of an IgE-ricin A chain conjugate on rat skin histamine content.
Immunotoxins--toxins covalently conjugated to specific antibodies--have been studied as possible agents in the treatment of cancer. The avid binding of IgE antibodies to FcR on mast cells and basophils suggested the possible use of an IgE-immunotoxin in the treatment of malignant mastocytosis or as a method to generate mast cell-depleted animals for study. To this end, the effect of a covalent conjugate of rat myeloma IgE and ricin A chain on rat cutaneous mast cells was examined in vivo. IgE-ricin A chain was capable of binding to and sensitizing cutaneous mast cells in vivo as indicated by a bluing response to intracutaneous anti-ricin A chain. IgE-ricin A chain, given either as a single dose or, even more effectively, as two split doses, significantly reduced cutaneous histamine content for 6 to 8 days. Neither a mixture of IgE and ricin A chain that were not conjugated nor the induction of cutaneous mast cell degranulation with anti-IgE affected cutaneous histamine levels. Therefore, IgE-ricin A chain produces a prolonged depletion of cutaneous histamine levels.
D000818:Animals; D001491:Basophils / Q000276:immunology; D004306:Dose-Response Relationship, Immunologic; D004591:Electrophoresis, Polyacrylamide Gel; D006636:Histamine Release / Q000187:drug effects*; D007073:Immunoglobulin E / Q000502:physiology*; D000922:Immunotoxins / Q000138:chemical synthesis / Q000302:isolation & purification / Q000494:pharmacology*; D007942:Leukemia, Experimental / Q000276:immunology; D008407:Mast Cells / Q000276:immunology; D014176:Protein Biosynthesis; D051381:Rats; D011919:Rats, Inbred Strains; D012276:Ricin / Q000494:pharmacology*; D012867:Skin / Q000276:immunology*
D000922:Immunotoxins; D007073:Immunoglobulin E; D012276:Ricin